{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:56:50Z","timestamp":1767920210282,"version":"3.49.0"},"reference-count":12,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1001\/jamadermatol.2021.5625","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T16:02:36Z","timestamp":1643817756000},"page":"242","source":"Crossref","is-referenced-by-count":3,"title":["Hair Are the Rankings\u20145-\u03b1 Reductase Inhibitors and Minoxidil in Male Androgenetic Alopecia"],"prefix":"10.1001","volume":"158","author":[{"given":"Kathie P.","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Brigham and Women\u2019s Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryanne M.","family":"Senna","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"8","key":"ded210025r1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2021.2196","article-title":"Health-related quality of life, depression, and self-esteem in patients with androgenetic alopecia: a systematic review and meta-analysis.","volume":"157","author":"Huang","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"12","key":"ded210025r2","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1111\/jocd.v20.12","article-title":"Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.","volume":"20","author":"Nestor","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"5","key":"ded210025r3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/14656566.2020.1721463","article-title":"A review of the treatment of male pattern hair loss.","volume":"21","author":"York","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"ded210025r4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/jamadermatol.2020.3384","article-title":"Ongoing concerns regarding finasteride for the treatment of male-pattern androgenetic alopecia.","volume":"157","author":"Ho","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"1","key":"ded210025r5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamadermatol.2020.3385","article-title":"Investigation of suicidality and psychological adverse events in patients treated with finasteride.","volume":"157","author":"Nguyen","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"3","key":"ded210025r6","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13379","article-title":"5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.","volume":"33","author":"Dhurat","year":"2020","journal-title":"Dermatol Ther"},{"key":"ded210025r7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2147\/CIA","article-title":"The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis.","volume":"14","author":"Zhou","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"1","key":"ded210025r8","first-page":"12","article-title":"Adverse sexual effects of treatment with finasteride or dutasteride for male androgenetic alopecia: a systematic review and meta-analysis.","volume":"99","author":"Lee","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"ded210025r9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jaad.2020.12.053","article-title":"Coming full circle (almost): Low dose oral minoxidil for alopecia.","volume":"84","author":"Heymann","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"ded210025r10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety.","volume":"84","author":"Randolph","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"ded210025r11","article-title":"Relative efficacy of minoxidil and the 5-a reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis.","author":"Gupta","journal-title":"JAMA Dermatol"},{"issue":"2","key":"ded210025r12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/09546634.2013.813011","article-title":"The efficacy and safety of 5a-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride.","volume":"25","author":"Gupta","year":"2014","journal-title":"J Dermatolog Treat"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2788261\/jamadermatology_huang_2022_ed_210025_1646938270.98701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T15:03:05Z","timestamp":1647442985000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2788261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.5625","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}